ELS vs NUVB vs SUI vs KYMR

For growth investors, Nuvation Bio Inc.

(NUVB) is the stronger pick with 699. 0% revenue growth year-over-year, versus -27. 9% for Sun Communities, Inc. (SUI). Sun Communities, Inc. (SUI) offers the better valuation at 11. 6x trailing P/E (47. 1x forward), making it the more compelling value choice. Analysts rate Equity LifeStyle Properties, Inc. (ELS) a "Buy" — based on 21 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.

On trailing P/E, Sun Communities, Inc.

(SUI) is the cheapest at 11. 6x versus Equity LifeStyle Properties, Inc. at 32. 8x. On forward P/E, Equity LifeStyle Properties, Inc. is actually cheaper at 31. 1x — notably different from the trailing picture, reflecting expected earnings growth. The PEG ratio (P/E divided by earnings growth rate) is the most growth-adjusted single valuation metric: Sun Communities, Inc. wins at 0. 91x versus Equity LifeStyle Properties, Inc. 's 3. 01x — a PEG below 1. 0 traditionally signals the market is underpricing earnings growth.

Over the past 5 years, Kymera Therapeutics, Inc.

(KYMR) delivered a total return of +92. 1%, compared to -58. 3% for Nuvation Bio Inc. (NUVB). Over 10 years, the gap is even starker: KYMR returned +154. 4% versus NUVB's -51. 8%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.

By beta (market sensitivity over 5 years), Equity LifeStyle Properties, Inc.

(ELS) is the lower-risk stock at 0. 02β versus Nuvation Bio Inc. 's 2. 04β — meaning NUVB is approximately 9648% more volatile than ELS relative to the S&P 500. On balance sheet safety, Nuvation Bio Inc. (NUVB) carries a lower debt/equity ratio of 3% versus 185% for Equity LifeStyle Properties, Inc. — giving it more financial flexibility in a downturn.

By revenue growth (latest reported year), Nuvation Bio Inc.

(NUVB) is pulling ahead at 699. 0% versus -27. 9% for Sun Communities, Inc. (SUI). On earnings-per-share growth, the picture is similar: Sun Communities, Inc. grew EPS 1427% year-over-year, compared to -23. 8% for Kymera Therapeutics, Inc.. Over a 3-year CAGR, ELS leads at 3. 7% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.

Sun Communities, Inc.

(SUI) is the more profitable company, earning 59. 6% net margin versus -794. 4% for Kymera Therapeutics, Inc. — meaning it keeps 59. 6% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: ELS leads at 33. 8% versus -891. 3% for KYMR. At the gross margin level — before operating expenses — KYMR leads at 100. 0%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.

The PEG ratio (forward P/E divided by expected earnings growth rate) is the most precise measure of undervaluation relative to growth potential.

By this metric, Sun Communities, Inc. (SUI) is the more undervalued stock at a PEG of 0. 91x versus Equity LifeStyle Properties, Inc. 's 3. 01x. A PEG below 1. 0 is traditionally considered the threshold for growth-adjusted undervaluation. On forward earnings alone, Equity LifeStyle Properties, Inc. (ELS) trades at 31. 1x forward P/E versus 47. 1x for Sun Communities, Inc. — 16. 0x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for NUVB: 157. 3% to $12. 40.

In this comparison, SUI (6.

6% yield), ELS (3. 2% yield) pay a dividend. NUVB, KYMR do not pay a meaningful dividend and should not be held primarily for income.

For long-horizon retirement investors, Equity LifeStyle Properties, Inc.

(ELS) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0. 02), 3. 2% yield, +106. 7% 10Y return). Nuvation Bio Inc. (NUVB) carries a higher beta of 2. 04 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (ELS: +106. 7%, NUVB: -51. 8%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.

These companies operate in different sectors (ELS (Real Estate) and NUVB (Healthcare) and SUI (Real Estate) and KYMR (Healthcare)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.

In terms of investment character: ELS is a mid-cap income-oriented stock; NUVB is a small-cap high-growth stock; SUI is a mid-cap deep-value stock; KYMR is a small-cap quality compounder stock. ELS, SUI pay a dividend while NUVB, KYMR do not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.